InvestSMART

SomnoMed Limited (ASX: SOM) - Announcements

Current share price for SOM : $0.460 0.02 (4.17%)+

ASX company news and announcements for SomnoMed Limited (SOM) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All SomnoMed Limited (SOM) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than SomnoMed Limited (SOM), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for SomnoMed Limited (SOM)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$101 SomnoMed exceeds 200,000 patients 10 Nov 2014 9:41AM $2.550 $0.460 fallen by 81.96%
$101 Appendix 4C - quarterly 16 Oct 2014 10:01AM $2.400 $0.460 fallen by 80.83%
$101 New records in September confirm guidance 16 Oct 2014 9:59AM $2.320 $0.460 fallen by 80.17%
$101 Preliminary Final Report 21 Aug 2014 9:12AM $1.800 $0.460 fallen by 74.44%
$101 Share Purchase Plan Offer and Rules 30 Jul 2014 6:16PM $1.750 $0.460 fallen by 73.71%
$101 Share Placement and 2014 Share Purchase Plan 25 Jul 2014 12:00PM $1.755 $0.460 fallen by 73.79%
$101 Trading Halt 24 Jul 2014 9:32AM $1.840 $0.460 fallen by 75%
$101 Appendix 4C - quarterly 23 Jul 2014 9:22AM $1.840 $0.460 fallen by 75%
$101 New sales records in Q4 & increasing growth prospects14/15 23 Jul 2014 9:22AM $1.840 $0.460 fallen by 75%
$101 SomnoMed takes over Italian Distribution 10 Jul 2014 10:04AM $1.640 $0.460 fallen by 71.95%
$101 SomnoMed USA receives 510K for Somnodent Fusion 24 Jun 2014 10:39AM $1.460 $0.460 fallen by 68.49%
$101 SomnoMed starts business in Spain and Portugal 26 May 2014 10:52AM $1.430 $0.460 fallen by 67.83%
$101 SomnoMed enters UK - Ireland market 16 May 2014 10:09AM $1.500 $0.460 fallen by 69.33%
$101 SomnoMed commences business in Finland 1 May 2014 12:07PM $1.460 $0.460 fallen by 68.49%
$101 Appendix 4C - quarterly 10 Apr 2014 10:06AM $1.585 $0.460 fallen by 70.98%
$101 SomnoMed achieves 28% volume growth in Q3 10 Apr 2014 10:04AM $1.585 $0.460 fallen by 70.98%
$101 Half Yearly Report and Accounts 26 Feb 2014 9:19AM $1.630 $0.460 fallen by 71.78%
$101 Appendix 4C - quarterly 16 Jan 2014 10:39AM $1.300 $0.460 fallen by 64.62%
$101 SomnoMed accelerates growth in Q2 16 Jan 2014 10:39AM $1.300 $0.460 fallen by 64.62%
$101 SomnoMed exceeds 150,000 patients wordwide 21 Nov 2013 10:30AM $1.300 $0.460 fallen by 64.62%
$101 Appendix 4C - quarterly 25 Oct 2013 10:51AM $1.270 $0.460 fallen by 63.78%
$101 SomnoMed expands in Korea 17 Oct 2013 9:16AM $1.200 $0.460 fallen by 61.67%
$101 Preliminary Final Report 27 Aug 2013 10:01AM $1.240 $0.460 fallen by 62.90%
$101 Appendix 4C - quarterly 19 Jul 2013 10:13AM $1.200 $0.460 fallen by 61.67%
$101 SomnoMed posts strong cash position 19 Jul 2013 10:12AM $1.200 $0.460 fallen by 61.67%

551 - 575 of 675 results

Page 23 of 27

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.